Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marta Milewska-Jędrzejczak"'
Neuromyelitis optica spectrum disorder (NMOSD) – diagnosis, epidemiology, clinical course, treatment
Autor:
Agnieszka Damiza-Detmer, Marta Milewska-Jędrzejczak, Małgorzata Pawełczyk, Izabela Damiza, Andrzej Głąbiński
Publikováno v:
Aktualności Neurologiczne, Vol 19, Iss 1, Pp 19-26 (2019)
Devic’s disease (neuromyelitis optica, NMO) was first described under this name in 1894, and it was originally thought of as a variant of multiple sclerosis. However, following the discovery of anti-aquaporin-4 antibodies (anti-Aq4-Ab), neuromyelit
Externí odkaz:
https://doaj.org/article/adb6e71840fe4d4d8641eece574d9c99
Publikováno v:
Aktualności Neurologiczne, Vol 19, Iss 1, Pp 13-18 (2019)
Neuroplasticity is the ability of the brain to adjust to internal and external environmental changes that physiologically take place during the entire life. Particularly interesting is the response of the brain to damage in patients with multiple scl
Externí odkaz:
https://doaj.org/article/fd62b1500d134dacbf87736a6b8ad7e4
Publikováno v:
Aktualności Neurologiczne, Vol 18, Iss 4, Pp 165-170 (2018)
Rheumatic diseases are characterised by damage to connective tissue, which is most frequently autoimmune in nature. The inflammation resulting from auto-aggression involves various organs and the heterogenous clinical symptoms depend on the intensity
Externí odkaz:
https://doaj.org/article/614d1d703b85476ea7a5e652cac220f0
Autor:
Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, Marcin Wnuk, Monika Marona, Klaudia Nowak, Agnieszka Słowik, Anna Jamroz-Wiśniewska, Konrad Rejdak, Beata Lech, Małgorzata Popiel, Iwona Rościszewska-Żukowska, Adam Perenc, Halina Bartosik-Psujek, Mariola Świderek-Matysiak, Małgorzata Siger, Agnieszka Ciach, Agata Walczak, Anna Jurewicz, Mariusz Stasiołek, Karolina Kania, Klara Dyczkowska, Alicja Kalinowska-Łyszczarz, Weronika Galus, Anna Walawska-Hrycek, Ewa Krzystanek, Justyna Chojdak-Łukasiewicz, Jakub Ubysz, Anna Pokryszko-Dragan, Katarzyna Kapica-Topczewska, Monika Chorąży, Marcin Bazylewicz, Anna Mirończuk, Joanna Kulikowska, Jan Kochanowicz, Marta Białek, Małgorzata Stolarz, Katarzyna Kubicka-Bączyk, Natalia Niedziela, Natalia Morawiec, Monika Adamczyk-Sowa, Aleksandra Podlecka-Piętowska, Monika Nojszewska, Beata Zakrzewska-Pniewska, Elżbieta Jasińska, Jacek Zaborski, Marta Milewska-Jędrzejczak, Jacek Zwiernik, Beata Zwiernik, Andrzej Potemkowski, Waldemar Brola, Alina Kułakowska
Publikováno v:
Vaccines, Vol 10, Iss 5, p 763 (2022)
(1) Background: The present study aims to report the side effects of vaccination against coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) who were being treated with disease-modifying therapies (DMTs) in Poland. (2) Met
Externí odkaz:
https://doaj.org/article/a6eeebc797524f8383584d3005689ac4
Autor:
Beata Zakrzewska-Pniewska, Monika Adamczyk-Sowa, Stanisław Rusek, Olga Zajkowska, Katarzyna Strzalińska, Jan Kochanowicz, Alina Kułakowska, Sławomir Wawrzyniak, Anna Narożnik, Anna Pokryszko-Dragan, Małgorzata Fudala, Adam Stępień, Magdalena Noga, Iwona Kurkowska-Jastrzębska, Andrzej Borysowicz, Krzysztof Nosek, Violetta Ptasznik, Ewa Gruszka, Andrzej Tutaj, Beata Zwiernik, Anna Michałowska, Halina Bartosik-Psujek, Izabela Paprocka, Aleksandra Podlecka-Piętowska, Agata Włodek, Joanna Kulikowska, Adam Perenc, Marcin Wnuk, Bożena Lewańczyk, Anetta Lasek-Bal, Karolina Kania, Małgorzata Pawełczyk, Marta Kucharska-Lipowska, Sławomir Budrewicz, Monika Chorąży, Anna Litwin, Michał Lipowski, Małgorzata Popiel, Katarzyna Gołuch, Monika Marona, Marta Milewska-Jędrzejczak, Maciej Maciejowski, Katarzyna Maciejowska, Henryka Lejmel, Jacek Zwiernik, Monika Nojszewska, Beata Lech, Katarzyna Kapica-Topczewska, Piotr Sobolewski, Agata Czarnowska, Katarzyna Kubicka-Bączyk, Aleksandra Pawlos, Anna Niezgodzińska-Maciejek, Elżbieta Jasińska, Przemysław Puz, Marta Białek, Agnieszka Slowik, Katarzyna Kurowska, Waldemar Brola, Joanna Tarasiuk, Alicja Kalinowska-Łyszczarz
Publikováno v:
Neurologia i Neurochirurgia Polska. 55:212-222
Introduction. The aim of this study was to report the course and outcome of SARS-CoV-2 infection in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs) in Poland. A major concern for neurologists worldwide is the course a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870d20249769d1abbe0301fcdbe69dc1
https://doi.org/10.5603/pjnns.a2021.0031
https://doi.org/10.5603/pjnns.a2021.0031
Autor:
Marta Milewska-Jędrzejczak, Piotr Szpakowski, Dominika Książek-Winiarek, Igor A. Bednarski, Elzbieta Miller, Andrzej Głąbiński
Publikováno v:
Aktualności Neurologiczne. 21:173-177
Introduction: Neuroplasticity is the function of the central nervous system that allows structural and functional reorganisation in response to external and internal factors. It is a crucial aspect that allows for the restoration of motor functions i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba8efe12b254ba692a5ec5128c6282ae
https://doi.org/10.15557/an.2020.0021
https://doi.org/10.15557/an.2020.0021
Publikováno v:
Journal of Clinical Medicine. 12:1880
Physical rehabilitation and physical activity are known non-pharmacological methods of treating multiple sclerosis. Both lead to an improvement in physical fitness in patients with movement deficits while improving cognitive function and coordination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6e683b52cfb253da618ae98920d5236
https://doi.org/10.3390/jcm12051880
https://doi.org/10.3390/jcm12051880
Publikováno v:
Aktualności Neurologiczne, Vol 19, Iss 1, Pp 13-18 (2019)
Neuroplasticity is the ability of the brain to adjust to internal and external environmental changes that physiologically take place during the entire life. Particularly interesting is the response of the brain to damage in patients with multiple scl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d92b5e2408dc8724cc04ab190f79b2
https://doi.org/10.15557/an.2019.0003
https://doi.org/10.15557/an.2019.0003
Neuromyelitis optica spectrum disorder (NMOSD) – diagnosis, epidemiology, clinical course, treatment
Autor:
Andrzej Głąbiński, Izabela Damiza, Agnieszka Damiza-Detmer, Małgorzata Pawełczyk, Marta Milewska-Jędrzejczak
Publikováno v:
Aktualności Neurologiczne, Vol 19, Iss 1, Pp 19-26 (2019)
Devic’s disease (neuromyelitis optica, NMO) was first described under this name in 1894, and it was originally thought of as a variant of multiple sclerosis. However, following the discovery of anti-aquaporin-4 antibodies (anti-Aq4-Ab), neuromyelit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::326d453de42e83dc7868a61124088d9c
http://www.neurologia.com.pl/index.php/issues/2019-vol-19-no-1/neuromyelitis-optica-spectrum-disorder-nmosd-diagnosis-epidemiology-clinical-course-treatment?aid=1033
http://www.neurologia.com.pl/index.php/issues/2019-vol-19-no-1/neuromyelitis-optica-spectrum-disorder-nmosd-diagnosis-epidemiology-clinical-course-treatment?aid=1033
Autor:
Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, Marcin Wnuk, Monika Marona, Klaudia Nowak, Agnieszka Słowik, Anna Jamroz-Wiśniewska, Konrad Rejdak, Beata Lech, Małgorzata Popiel, Iwona Rościszewska-Żukowska, Adam Perenc, Halina Bartosik-Psujek, Mariola Świderek-Matysiak, Małgorzata Siger, Agnieszka Ciach, Agata Walczak, Anna Jurewicz, Mariusz Stasiołek, Karolina Kania, Klara Dyczkowska, Alicja Kalinowska-Łyszczarz, Weronika Galus, Anna Walawska-Hrycek, Ewa Krzystanek, Justyna Chojdak-Łukasiewicz, Jakub Ubysz, Anna Pokryszko-Dragan, Katarzyna Kapica-Topczewska, Monika Chorąży, Marcin Bazylewicz, Anna Mirończuk, Joanna Kulikowska, Jan Kochanowicz, Marta Białek, Małgorzata Stolarz, Katarzyna Kubicka-Bączyk, Natalia Niedziela, Paweł Warmus, Monika Adamczyk-Sowa, Aleksandra Podlecka-Piçtowska, Monika Nojszewska, Beata Zakrzewska-Pniewska, Elżbieta Jasińska, Jacek Zaborski, Marta Milewska-Jȩdrzejczak, Jacek Zwiernik, Beata Zwiernik, Andrzej Potemkowski, Waldemar Brola, Alina Kułakowska
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Background and ObjectivesSince vaccination against COVID-19 is available for over a year and the population of immunized individuals with autoimmune disorders is higher than several months before, an evaluation of safety and registered adverse events
Externí odkaz:
https://doaj.org/article/6e6c37368df744429fb87b66db39960f